LTC Non-qualified Plans

Long-term care (LTC) non-qualified plans are LTC insurance policies that do not meet the criteria set by the federal government to qualify for tax benefits. These policies are offered by insurance companies to cover the costs of long-term care services, such as nursing home care, home health care, and adult day care.

Here are some key features of LTC non-qualified plans:

• Premiums are not tax-deductible: Unlike qualified plans, premiums paid for non-qualified LTC insurance policies are not tax-deductible.

• Benefits are tax-free: The benefit payments received from a non-qualified LTC insurance policy are not subject to federal income tax.

• No minimum benefit requirements: Non-qualified plans do not have to meet minimum benefit requirements like qualified plans do. This allows for more flexibility in designing policies to meet specific needs.

• No inflation protection required: Qualified LTC plans must offer inflation protection as an optional rider or built-in feature. Non-qualified plans do not have this requirement.

• No restrictions on benefit triggers: Qualified LTC plans must include certain triggers for benefits, such as the inability to perform activities of daily living (ADLs) or cognitive impairment. Non-qualified plans have more flexibility in determining the triggers for benefit payments.

• More relaxed underwriting: Non-qualified plans often have more relaxed underwriting requirements than qualified plans, making them easier to obtain for those with pre-existing health conditions. However, this may result in higher premiums.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.